New Hepatitis D Treatment Hits 88% Success in 2-Year Trial
A groundbreaking combination therapy has left nearly 9 in 10 hepatitis D patients with no detectable virus after two years of treatment. The results could transform care for a disease that often leads to liver failure within five years.